Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8835
Intraperitoneal Mitoxantrone vs. Intraperitoneal FUdR for Ovarian Cancer Patients with Minimal Residual Disease after Second-Look Surgery, A Randomized Phase II Pilot
Research Committee(s)
Gynecologic Cancer
Activated
12-01-1988
Closed
01-01-1994
Closed
Phase
Accrual
65%
Published
SWOG Clinical Trial Number
SWOG-8795 (INT-0094) (EST-1888)
Randomized Prospective Comparison of Bacillus Calmette-Guerin and Mitomycin-C Therapy and Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder with DNA Flow Cytometric Analysis
Research Committee(s)
Genitourinary Cancer
Activated
12-01-1988
Closed
05-15-1992
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-8719
Evaluations of Didemnin B or Ifosfamide/Mesna in Endocrine Resistant Prostate Cancer and of Ifosfamide/Mesna in Patients without Prior Endocrine Manipulation
Research Committee(s)
Genitourinary Cancer
Activated
11-01-1988
Closed
05-15-1993
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-8614
Temporarily Closed: 4/15/90, Chemotherapy of Gastric Cancer with VM-26
Activated
10-15-1988
Closed
09-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8809
A Phase III Study of Alpha-Interferon Consolidation Following Intensive Chemotherapy with ProMACE- MOPP (Day 1-8) in Patients with Low Grade Malignant Lymphomas
Research Committee(s)
Lymphoma
Activated
10-01-1988
Closed
11-15-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8801
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-8609
VM-26 (Teniposide) Single Drug Treatment for Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
09-15-1988
Closed
11-15-1990
Closed
Phase
Accrual
17%
SWOG Clinical Trial Number
SWOG-8752
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer
Activated
09-15-1988
Closed
07-15-1990
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8741
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Carcinoma of the Breast
Activated
09-15-1988
Closed
11-15-1990
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8811
Phase II Trial of 5-Fluorouracil and High Dose Folinic Acid as First or Second Line Therapy for Advanced Breast Cancer
Activated
09-01-1988
Closed
11-15-1990
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
SWOG-8610
Prospective Randomized Clinical Trial of the Capillary Cloning System for Patients with Extensive Small-Cell Lung Cancer
Activated
09-01-1988
Closed
11-01-1989
Closed
Phase
Accrual
67%
Published
SWOG Clinical Trial Number
SWOG-8746
Phase I Trial of Dose Intensive Chemotherapy Combined with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Breast Cancer
Activated
09-01-1988
Closed
09-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8737
Phase III AZQ 24-hour Infusion versus BCNU for Adult High Grade Gliomas
Activated
08-15-1988
Closed
05-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8794
Treatment of Pathologic Stage C Carcinoma of the Prostate with Adjuvant Radiotherapy
Research Committee(s)
Genitourinary Cancer
Activated
08-15-1988
Closed
01-01-1997
Closed
Phase
Accrual
25%
SWOG Clinical Trial Number
SWOG-8806
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594)
Activated
08-15-1988
Closed
11-15-1990
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
SWOG-8850
Cisplatin and Novobiocin in the Treatment of Stage IV, Stage IIIb or Locally Recurrent Tumor After Radiation Therapy of Non-Small Cell Lung Cancer (NSCLC)
Activated
08-15-1988
Closed
06-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8500
Second-Line Treatment of Advanced Measurable Ovarian Cancer with CHIP
Activated
08-01-1988
Closed
11-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8742
Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Metastatic Sarcoma
Activated
08-01-1988
Closed
12-01-1989
Closed
Phase
Accrual
27%
SWOG Clinical Trial Number
SWOG-8744
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma
Activated
08-01-1988
Closed
11-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8723
Evaluation of Amonafide in Disseminated Malignant Melanoma
Activated
07-15-1988
Closed
06-01-1990